Kyowa Kirin
World Rank (Jan-05-2024)
1,811
Market Cap (Jan-05-2024)
8.943 Billion USD
World Rank (Jul-30-2023)
1,644
Market Cap (Jul-30-2023)
10.251 Billion USD
World Rank (Dec-25-2022)
1,297
Market Cap (Dec-25-2022)
12.269 Billion USD
World Rank (Jan-07-2022)
1,412
Market Cap (Jan-07-2022)
14.25 Billion USD
Annual Revenue in USD
2,822 Million USD
Annual Net Income in USD
380 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Kyowa Kirin is a company that develops, manufactures, and markets pharmaceuticals. The Company produces anti-allergic agent, treating hypertension and angina pectoris agent, ulcerative colitis agent, anti-epileptic agent, and more. The headquarters is in Japan.
Company Website
Wikipedia